Evozyne has filed a notice of an exempt offering of securities to raise $100,000,001.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Evozyne is raising $100,000,001.00 in new funding. Sources indicate that as part of senior management Senior Executive, Jeffrey Aronin played a key role in securing…
